October 13, 2009 08:30 ET

SOHM India Expands Pharmaceutical Line to Include High Growth Veterinary Medicines

Limited Competitors and Low Export Barriers Make Veterinary Medicines a Very Attractive Niche Pharmaceutical Market

BUENA PARK, CA--(Marketwire - October 13, 2009) - SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, announced today that it has entered the veterinary medicine market with a series of products produced in India for both domestic and international sales. SOHM has identified certain veterinary products in the dosage form of bolus tablets and oral liquid that can be easily manufactured through a third party manufacturing agreement. The veterinary market is one of the fastest growing markets in India with limited competition and few players. The Company expects a formal product launch in December 2009.

Nitin Shah, Vice President of Marketing at SOHM India, stated, "We have explored many possibilities for fast revenue growth and veterinary medicines stands out because of the ease of entry into the market and opportunities to take market share. The export of the veterinary medicines is also comparatively easy and it does not require extensive documentation to register our products in different countries. The niche market is very attractive and we feel this area will be a large contributor to corporate revenue and earnings in 2010."

About SOHM, Inc.

SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters is located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia.

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    SOHM, Inc.
    Investor Relations
    (714) 522-6700
    Email Contact